Experimental medullary aplasia

Lynell Warren Klassen, John Birks, Elizabeth Allen, Clifford W. Gurney

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

Young adult mice given 6 μCi per gram of body weight of 89Sr, a bone-seeking beta-emitting isotope, develop bone marrow aplasia. Compensatory extramedullary hematopoiesis is observed in the spleen, and the hematocrit remains essentially unchanged. Following splenectomy, even as late as 37 days after administration of radiostrontium, most of the animals die of pancytopenia. 59Fe incorporation by newly formed red cells remains unchanged following 89Sr administration. 59Fe incorporation following splenectomy is 42 per cent in control animals and 58 per cent in sham-operated control animals. However, after splenectomy it drops to 0.6 per cent in mice previously given 6 μCi per gram of 89Sr. Therefore, red cells produced in animals after radiostrontium administration are essentially of splenic origin, while normal animals produce only a small fraction of their erythrocytes in the spleen. Peripheral counts of mice given radiostrontium reveal a persistent lymphopenia, neutropenia, and slight reticulocytosis while thrombocyte values are normal. The radiation dose received by the spleen, as determined by LiF dosimeters, is cumulatively 40.2 rads 1 day, 54.2 rads 2 days, and 75.0 rads 8 days postinjection of 6 μCi 89Sr per gram of body weight. The marked leukopenia does not appear to be dose-related over the 2 to 6 μCi per gram range. These observations suggest intracorporeal irradiation of a radiosensitive fraction of the blood lymphocytes as they circulate through the marrow may be a factor in the production of leukopenia.

Original languageEnglish (US)
Pages (from-to)8-17
Number of pages10
JournalThe Journal of Laboratory and Clinical Medicine
Volume80
Issue number1
StatePublished - Jan 1 1972

Fingerprint

Animals
Splenectomy
Spleen
Leukopenia
Bone
Bone Marrow
Reticulocytosis
Cells
Body Weight
Extramedullary Hematopoiesis
Pancytopenia
Lymphopenia
Lymphocytes
Dosimeters
Neutropenia
Hematocrit
Isotopes
Dosimetry
Young Adult
Reference Values

ASJC Scopus subject areas

  • Medicine(all)
  • Pathology and Forensic Medicine

Cite this

Klassen, L. W., Birks, J., Allen, E., & Gurney, C. W. (1972). Experimental medullary aplasia. The Journal of Laboratory and Clinical Medicine, 80(1), 8-17.

Experimental medullary aplasia. / Klassen, Lynell Warren; Birks, John; Allen, Elizabeth; Gurney, Clifford W.

In: The Journal of Laboratory and Clinical Medicine, Vol. 80, No. 1, 01.01.1972, p. 8-17.

Research output: Contribution to journalArticle

Klassen, LW, Birks, J, Allen, E & Gurney, CW 1972, 'Experimental medullary aplasia', The Journal of Laboratory and Clinical Medicine, vol. 80, no. 1, pp. 8-17.
Klassen, Lynell Warren ; Birks, John ; Allen, Elizabeth ; Gurney, Clifford W. / Experimental medullary aplasia. In: The Journal of Laboratory and Clinical Medicine. 1972 ; Vol. 80, No. 1. pp. 8-17.
@article{0590c72cef0845299faaef51171bf067,
title = "Experimental medullary aplasia",
abstract = "Young adult mice given 6 μCi per gram of body weight of 89Sr, a bone-seeking beta-emitting isotope, develop bone marrow aplasia. Compensatory extramedullary hematopoiesis is observed in the spleen, and the hematocrit remains essentially unchanged. Following splenectomy, even as late as 37 days after administration of radiostrontium, most of the animals die of pancytopenia. 59Fe incorporation by newly formed red cells remains unchanged following 89Sr administration. 59Fe incorporation following splenectomy is 42 per cent in control animals and 58 per cent in sham-operated control animals. However, after splenectomy it drops to 0.6 per cent in mice previously given 6 μCi per gram of 89Sr. Therefore, red cells produced in animals after radiostrontium administration are essentially of splenic origin, while normal animals produce only a small fraction of their erythrocytes in the spleen. Peripheral counts of mice given radiostrontium reveal a persistent lymphopenia, neutropenia, and slight reticulocytosis while thrombocyte values are normal. The radiation dose received by the spleen, as determined by LiF dosimeters, is cumulatively 40.2 rads 1 day, 54.2 rads 2 days, and 75.0 rads 8 days postinjection of 6 μCi 89Sr per gram of body weight. The marked leukopenia does not appear to be dose-related over the 2 to 6 μCi per gram range. These observations suggest intracorporeal irradiation of a radiosensitive fraction of the blood lymphocytes as they circulate through the marrow may be a factor in the production of leukopenia.",
author = "Klassen, {Lynell Warren} and John Birks and Elizabeth Allen and Gurney, {Clifford W.}",
year = "1972",
month = "1",
day = "1",
language = "English (US)",
volume = "80",
pages = "8--17",
journal = "Translational Research",
issn = "1931-5244",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Experimental medullary aplasia

AU - Klassen, Lynell Warren

AU - Birks, John

AU - Allen, Elizabeth

AU - Gurney, Clifford W.

PY - 1972/1/1

Y1 - 1972/1/1

N2 - Young adult mice given 6 μCi per gram of body weight of 89Sr, a bone-seeking beta-emitting isotope, develop bone marrow aplasia. Compensatory extramedullary hematopoiesis is observed in the spleen, and the hematocrit remains essentially unchanged. Following splenectomy, even as late as 37 days after administration of radiostrontium, most of the animals die of pancytopenia. 59Fe incorporation by newly formed red cells remains unchanged following 89Sr administration. 59Fe incorporation following splenectomy is 42 per cent in control animals and 58 per cent in sham-operated control animals. However, after splenectomy it drops to 0.6 per cent in mice previously given 6 μCi per gram of 89Sr. Therefore, red cells produced in animals after radiostrontium administration are essentially of splenic origin, while normal animals produce only a small fraction of their erythrocytes in the spleen. Peripheral counts of mice given radiostrontium reveal a persistent lymphopenia, neutropenia, and slight reticulocytosis while thrombocyte values are normal. The radiation dose received by the spleen, as determined by LiF dosimeters, is cumulatively 40.2 rads 1 day, 54.2 rads 2 days, and 75.0 rads 8 days postinjection of 6 μCi 89Sr per gram of body weight. The marked leukopenia does not appear to be dose-related over the 2 to 6 μCi per gram range. These observations suggest intracorporeal irradiation of a radiosensitive fraction of the blood lymphocytes as they circulate through the marrow may be a factor in the production of leukopenia.

AB - Young adult mice given 6 μCi per gram of body weight of 89Sr, a bone-seeking beta-emitting isotope, develop bone marrow aplasia. Compensatory extramedullary hematopoiesis is observed in the spleen, and the hematocrit remains essentially unchanged. Following splenectomy, even as late as 37 days after administration of radiostrontium, most of the animals die of pancytopenia. 59Fe incorporation by newly formed red cells remains unchanged following 89Sr administration. 59Fe incorporation following splenectomy is 42 per cent in control animals and 58 per cent in sham-operated control animals. However, after splenectomy it drops to 0.6 per cent in mice previously given 6 μCi per gram of 89Sr. Therefore, red cells produced in animals after radiostrontium administration are essentially of splenic origin, while normal animals produce only a small fraction of their erythrocytes in the spleen. Peripheral counts of mice given radiostrontium reveal a persistent lymphopenia, neutropenia, and slight reticulocytosis while thrombocyte values are normal. The radiation dose received by the spleen, as determined by LiF dosimeters, is cumulatively 40.2 rads 1 day, 54.2 rads 2 days, and 75.0 rads 8 days postinjection of 6 μCi 89Sr per gram of body weight. The marked leukopenia does not appear to be dose-related over the 2 to 6 μCi per gram range. These observations suggest intracorporeal irradiation of a radiosensitive fraction of the blood lymphocytes as they circulate through the marrow may be a factor in the production of leukopenia.

UR - http://www.scopus.com/inward/record.url?scp=0015362632&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0015362632&partnerID=8YFLogxK

M3 - Article

VL - 80

SP - 8

EP - 17

JO - Translational Research

JF - Translational Research

SN - 1931-5244

IS - 1

ER -